Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: An individual patient data pooled analysis of the ABSORB trials

Azzalini, L., Ellis, S. G., Kereiakes, D. J., Kimura, T., Gao, R., Onuma, Y., Chevalier, B., Dressler, O., Crowley, A., Zhou, Z., Redfors, B., Serruys, P. W., & Stone, G. W. (2021). Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials. EuroIntervention, 17(12), e981–e988. https://doi.org/10.4244/eij-d-21-00263
Authors:
Lorenzo Azzalini
Stephen G. Ellis
Dean J. Kereiakes
Takeshi Kimura
Runlin Gao
Yoshinobu Onuma
Bernard Chevalier
Ovidiu Dressler
Aaron Crowley
Zhipeng Zhou
Björn Redfors
Patrick W. Serruys
Gregg W. Stone
Affiliated Authors:
Björn Redfors
Author Keywords:
adjunctive pharmacotherapy
bioresorbable scaffolds
clinical trials
stent thrombosis
Publication Type:
Article
Unique ID:
10.4244/EIJ-D-21-00263
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: